RxDoctor Payments Data

Jessica Burgess

Nurse Practitioner · Cabot, ARNPI 1114502176

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $760, 6.2 times the $123 reported in 2021.

$2,708in general payments, 2019–2025

Across 166 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$491
  • Pfizer$340
  • Novo Nordisk$268
  • Lilly USA, LLC$198
  • AstraZeneca$144
  • GSK$130
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$2,708100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,708 in reported general payments places this provider in the 85th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$15,376
Azelastine Hcl19$364
Fluticasone Propionate17$197
Metformin Hcl14$135
Amlodipine Besylate17$134
Atorvastatin Calcium13$100
Lisinopril25$80
Doxycycline Hyclate12$79
Levothyroxine Sodium15$74
Meloxicam13$63
Azithromycin17$38

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$268$15,37616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Cabot

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →